99mTc-MIP-1404

DRUG3 trials

Sponsors

Turku University Hospital, Molecular Insight Pharmaceuticals, Inc.

Conditions

Prostate CancerProstate cancer

Phase 1

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

CompletedNCT01572701

Molecular Insight Pharmaceuticals, Inc.Prostate Cancer

Start: 2012-01-31Updated: 2015-11-25

99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404

CompletedNCT01654874

Molecular Insight Pharmaceuticals, Inc.Prostate Cancer

Start: 2012-07-31Updated: 2015-11-25

Phase 2

99mTc-MIP-1404 SPECT/CT for primary PROstate cancer STAging: comparative prospective, randomized trial to present guideline imaging, PROSTAMIP

RecruitingCTIS2024-516083-28-00

Turku University HospitalProstate cancer

Start: 2022-06-01Target: 320Updated: 2024-12-20